Piscataway, NJ May 23, 2012 -- GenScript USA Incorporation announced with honor to continue its sponsorship to the 2012 iGEM competition and the participating teams.
International Genetically Engineered Machine (iGEM) competition is the largest undergraduate Synthetic Biology competition with 190 teams from top universities worldwide. Organized by the Massachusetts Institute of Technology (MIT), this event is one of important activities for the young students to explore the Synthetic Biology. Since 2009, GenScript, as a leading company in the synthetic biology field, has continued sponsoring iGEM teams by providing superior quality gene synthesis service to facilitate the teams building novel biological systems.
Our sponsored teams have won gold and silver medals in the past competitions. The iGEM teams receiving GenScript’s sponsorships come from California Tech, Johns Hopkins, Boston University, Peking University, University of St. Andrews, ITESM University, and Shanghai JiaoTong University, etc. We believe the iGEM teams, empowered by our gene synthesis services, will prevail again in the 2012 world competition.
As a leading Gene Synthesis company, GenScript plays the pioneering role in the rapidly expanding synthetic biology field. Scientists in GenScript are designing and "scripting" their gene circuits for better biofuels, bio-medicines, and various bio-chemicals. GenScript is ready to assist your synthetic biology projects to make these magic "scripts" into true genes, which, in the hands of scientists, are mixed and matched to create marvelous organisms.
About GenScript USA, Inc.
GenScript USA, Inc., is a leading biology CRO focusing on early drug discovery and development services. Built on assembly-line mode, one-stop solution, continuous improvement, and stringent IP protection, GenScript provides a comprehensive portfolio of services that include Bio-Reagent, Bio-Assay, Lead Optimization, and Antibody Drug Development which can be effectively integrated into value chain and operations. GenScript is the largest gene synthesis provider in the U.S. Their customers include top pharmaceutical companies, major biotech firms and research institutions in over 70 countries.
Since its inception in 2003 from a short course at MIT, the International Genetically Engineered Machine competition (iGEM) has become the premiere undergraduate Synthetic Biology competition, an international sensation, and a significant force to the advancement of synthetic biology. 184 teams have participated in 2012 iGEM to dive into the synthetic biology area.
For further information, please contact:
Executive Vice President
GENSCRIPT USA Inc.